Document is current
Any future updates will be listed below
-
Authors
Raber, Susan R. https://orcid.org/0009-0000-2554-9719
Xie, Rujia
Rogers, Halley
Soto, Elena https://orcid.org/0009-0005-0999-1351
Arhin, Francis F. https://orcid.org/0009-0004-2118-685X
Stone, Gregory G.
Leister-Tebbe, Heidi
Chow, Joseph W. https://orcid.org/0000-0002-5934-5877
-
Funding
Funding for this research was provided by:
Pfizer
Biomedical Advanced Research and Development Authority (HHSO100201500029C)
Innovative Medicines Initiative (COMBACTE-CARE consortium)
- License Information
-
More Information
Article History
Received: 5 September 2025
Accepted: 4 November 2025
First Online: 21 November 2025
Declarations
:
: Susan Raber, Rujia Xie, Joseph W. Chow, and Francis F. Arhin are former employees of Pfizer. Halley Rogers, Elena Soto, Gregory G. Stone, and Heidi Leister-Tebbe are employees of Pfizer.
: Appropriate ethics approval and patient consent were obtained for the individual studies included here, as reported in the individual publications [ , ]. The studies were carried out in accordance with good clinical practice guidelines and the Declaration of Helsinki. Written informed consent was obtained from patients before screening. The final study protocols were approved by the relevant independent ethics committees and/or institutional review boards.
